Brand name: Atectura Breezhaler 125/260 TM
Active ingredients: indacaterol + mometasone
What it is used for
Atectura Breezhaler is indicated as a once-daily maintenance treatment of asthma in adults and adolescents 12 years of age and older where use of a combination of long-acting beta2-agonist and inhaled corticosteroid is appropriate:,- patients not adequately controlled with inhaled corticosteroids and "as needed" inhaled short-acting beta2-agonists or,- patients not adequately controlled with long-acting beta2-agonists and low dose of inhaled corticosteroids and "as needed" inhaled short-acting beta2-agonists
How to take it
The way to take this medicine is: Inhalation.
- Store below 25 degrees Celsius
- Protect from Light
- Protect from Moisture
- Store in Original Container
- Shelf lifetime is 24 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Natural transparent capsules containing a white to practically white powder, with the product code 'IM150-320' printed in black above two black bars on the body and a logo printed in black and surrounded by two black bars on the cap
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Consumer Medicines Information (CMI)
For side effects, taking other medicines and more
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
